Broncho Munal (lyophilized bacterial lysates)
/ Abiogen
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
January 02, 2024
Efficacy and safety of bacterial lysate OM-85 in the treatment of uncomplicated acute respiratory infections: a double-blind, placebo-controlled, multicenter, randomized trial
(PubMed, Ter Arkh)
- "The study confirmed the efficacy and safety of OM-85 in the complex treatment of ARI in adults."
Journal • Infectious Disease • Influenza • Novel Coronavirus Disease • Respiratory Diseases
August 04, 2023
Study of the Efficacy and Safety of Broncho-munal®, Capsules, 7 mg for the Treatment of Acute Uncomplicated Respiratory Tract Infections
(clinicaltrials.gov)
- P3 | N=556 | Completed | Sponsor: Sandoz | Not yet recruiting ➔ Completed
Trial completion • Infectious Disease • Respiratory Diseases
October 20, 2022
Study of the Efficacy and Safety of Broncho-munal®, Capsules, 7 mg for the Treatment of Acute Uncomplicated Respiratory Tract Infections
(clinicaltrials.gov)
- P3 | N=556 | Not yet recruiting | Sponsor: Sandoz
New P3 trial • Infectious Disease • Respiratory Diseases
July 04, 2021
Use of the Bacterial Lysate OM-85 in the Paediatric Population in Italy: A Retrospective Cohort Study.
(PubMed, Int J Environ Res Public Health)
- "OM-85 is effective in preventing both antibiotic prescriptions and RTIs in children."
Journal • Retrospective data • Infectious Disease • Pediatrics • Respiratory Diseases
1 to 4
Of
4
Go to page
1